103 results on '"Docosanol"'
Search Results
2. Efficacy and Safety of Acyclovir-penciclovir Cream Versus an Abreva in the Suppression of Herpes Simplex Virus Eruptions
- Author
-
Christopher Hull, Professor, Dermatology
- Published
- 2024
3. An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis
- Author
-
Ecogene 21
- Published
- 2020
4. Analysis of docosanol using GC/MS: Method development, validation, and application to ex vivo human skin permeation studies
- Author
-
Vijay Kumar Shankar, Mei Wang, Srinivas Ajjarapu, Praveen Kolimi, Bharathi Avula, Reena Murthy, Ikhlas Khan, and Sathyanarayana Narasimha Murthy
- Subjects
Docosanol ,Fatty alcohols ,Gas chromatography-mass spectrometry ,Topical formulation ,Skin permeation ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Docosanol is the only US Food and Drug Administration (FDA) approved over-the-counter topical product for treating recurrent oral-facial herpes simplex labialis. Validated analytical methods for docosanol are required to demonstrate the bioequivalence of docosanol topical products. A gas chromatography/selected ion monitoring mode mass spectrometry (GC/SIM-MS) method was developed and validated for docosanol determination in biological samples. Docosanol and isopropyl palmitate (internal standard) were separated on a high-polarity GC capillary column with (88% cyanopropy)aryl-polysiloxane employed as the stationary phase. The ions of m/z 83 and 256 were selected to monitor docosanol and isopropyl palmitate, respectively; the total run time was 20 min. The GC/SIM-MS method was validated in accordance with US FDA guidelines, and the results met the US FDA acceptance criteria. The docosanol calibration standards were linear in the 100–10000 ng/mL concentration range (R2>0.994). The recoveries for docosanol from the receptor fluid and skin homogenates were >93.2% and >95.8%, respectively. The validated method was successfully applied to analyze ex vivo human cadaver skin permeation samples. On applying Abreva® cream tube and Abreva® cream pump, the amount of docosanol that penetrated human cadaver skin at 48 h was 21.5 ± 7.01 and 24.0 ± 6.95 ng/mg, respectively. Accordingly, we concluded that the validated GC/SIM-MS was sensitive, specific, and suitable for quantifying docosanol as a quality control tool. This method can be used for routine analysis as a cost-effective alternative to other techniques.
- Published
- 2022
- Full Text
- View/download PDF
5. Suppression of Thiol-Dependent Antioxidant System and Stress Response in Methicillin-Resistant Staphylococcus aureus by Docosanol: Explication Through Proteome Investigation.
- Author
-
Lakshmi, Selvaraj Alagu, Prasath, Krishnan Ganesh, Tamilmuhilan, Kannapiran, Srivathsan, Adimoolam, Shafreen, Raja Mohamed Beema, Kasthuri, Thirupathi, and Pandian, Shunmugiah Karutha
- Abstract
The present study was aimed to investigate the effect of docosanol on the protein expression profile of methicillin-resistant Staphylococcus aureus (MRSA). Thus, two-dimensional gel electrophoresis coupled with MALDI-TOF MS technique was utilized to identify the differentially regulated proteins in the presence of docosanol. A total of 947 protein spots were identified from the intracellular proteome of both control and docosanol treated samples among which 40 spots were differentially regulated with a fold change greater than 1.0. Prominently, the thiol-dependent antioxidant system and stress response proteins are downregulated in MRSA, which are critical for survival during oxidative stress. In particular, docosanol downregulated the expression of Tpx, AhpC, BshC, BrxA, and YceI with a fold change of 1.4 (p = 0.02), 1.4 (p = 0.01), 1.6 (p = 0.002), 4.9 (p = 0.02), and 1.4 (p = 0.02), respectively. In addition, docosanol reduced the expression of proteins involved in purine metabolic pathways, biofilm growth cycle, and virulence factor production. Altogether, these findings suggest that docosanol could efficiently target the antioxidant pathway by reducing the expression of bacillithiol and stress-associated proteins. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. Analysis of docosanol using GC/MS: Method development, validation, and application to ex vivo human skin permeation studies.
- Author
-
Shankar, Vijay Kumar, Wang, Mei, Ajjarapu, Srinivas, Kolimi, Praveen, Avula, Bharathi, Murthy, Reena, Khan, Ikhlas, and Murthy, Sathyanarayana Narasimha
- Subjects
HERPES labialis ,GAS chromatography/Mass spectrometry (GC-MS) ,CAPILLARY columns ,GAS chromatography ,MASS spectrometry - Abstract
Docosanol is the only US Food and Drug Administration (FDA) approved over-the-counter topical product for treating recurrent oral-facial herpes simplex labialis. Validated analytical methods for docosanol are required to demonstrate the bioequivalence of docosanol topical products. A gas chromatography/selected ion monitoring mode mass spectrometry (GC/SIM-MS) method was developed and validated for docosanol determination in biological samples. Docosanol and isopropyl palmitate (internal standard) were separated on a high-polarity GC capillary column with (88% cyanopropy)aryl-polysiloxane employed as the stationary phase. The ions of m/z 83 and 256 were selected to monitor docosanol and isopropyl palmitate, respectively; the total run time was 20 min. The GC/SIM-MS method was validated in accordance with US FDA guidelines, and the results met the US FDA acceptance criteria. The docosanol calibration standards were linear in the 100–10000 ng/mL concentration range (R
2 >0.994). The recoveries for docosanol from the receptor fluid and skin homogenates were >93.2% and >95.8%, respectively. The validated method was successfully applied to analyze ex vivo human cadaver skin permeation samples. On applying Abreva® cream tube and Abreva® cream pump, the amount of docosanol that penetrated human cadaver skin at 48 h was 21.5 ± 7.01 and 24.0 ± 6.95 ng/mg, respectively. Accordingly, we concluded that the validated GC/SIM-MS was sensitive, specific, and suitable for quantifying docosanol as a quality control tool. This method can be used for routine analysis as a cost-effective alternative to other techniques. [Display omitted] • Docosanol is used to treat recurrent oral-facial herpes simplex labialis. • Analytical methods are required to demonstrate docosanol product bioequivalence. • A GC/SIM-MS docosanol method was developed and validated as per USFDA. • The GC/SIM-MS docosanol analytical method was sensitive, specific, and reproducible. • The method was employed to quantify docosanol human skin permeation samples. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
7. An Alternative Treatment for Vaginal Cuff Wart: a Case Report
- Author
-
Victoria Psomiadou, Christos Iavazzo, Athanasios Douligeris, Alexandros Fotiou, Anastasia Prodromidou, Nikolaos Mplontzos, Evgenia Karavioti, and George Vorgias
- Subjects
HPV ,vaginal cuff wart ,curcumin ,Indian Grapefruit (AMLA) ,aloe vera ,Docosanol ,Medicine - Abstract
Human papillomavirus (HPV) has been directly related to acuminate warts and cervical cancer, the second most common neoplasia among women. Given the lack of treatment against the virus itself, many medications have been utilised, mainly aiming in modifying the host’s immunological response. We present the case of a 54 years old postmenopausal patient with a history of vaginal cuff wart and HPV persistence that we managed in our clinic for 6 months with a mix of curcumin, aloe vera, amla and other natural ingredients. As the patient was found to be intolerant to imiquimod (one of the most common conservative methods of treatment) we attempted the use of curcumin, which was applied to the area of the wart three times per week for 6 months. Both clinical and colposcopical improvement was noted in regular clinic visits with regression of the lesion. The outcome of this case encourages our view that curcumin should be considered as a significant treatment modality against HPV infection and acuminate warts.
- Published
- 2020
- Full Text
- View/download PDF
8. THE CHANGES IN THE CONTENT OF ALIPHATIC ALCOHOLS IN BARLEY SEEDLINGS UNDER THE INFLUENCE OF AN ULTRAHIGH FREQUENCY ELECTROMAGNETIC FIELD
- Author
-
O. M. Soboleva, E. P. Kondratenko, A. S. Sukhikh, and M. G. Kurbanova
- Subjects
sprouts ,barley ,electromagnetic field ,microwave ,higher fatty alcohols ,docosanol ,begenyl alcohol ,tetracosanol ,lignocerine alcohol ,dodecanol ,laurine alcohol ,hexadecanol ,cetyl alcohol ,Biology (General) ,QH301-705.5 - Abstract
Background. Higher fatty alcohols are a valuable raw material for pharmacology and can serve as an adaptogen in crop production, reducing post-stress effects in the cultivation of crops. Policosanols are linear saturated aliphatic alcohols with carbon atoms ranging from 20–24 to 32–34. Cereal germ contains some of the policosanols and can serve as a potential source for the isolation, purification, and further use of this class of chemical compounds. The purpose of the research is to study the features of the higher fatty alcohols content in various anatomical organs of barley seedlings under the influence of an ultra-high frequency electromagnetic field. Materials and methods. The content of some higher fatty alcohols in barley seedlings after grain processing by ultrahigh frequency electromagnetic fields was determined by the method of chromatography-mass spectrometry. Results. The character of distribution of 4 fatty alcohols – tetraconanol (lignocerin alcohol), docosanol (begenyl alcohol), dodecanol (lauric alcohol) and hexadecanol (cetyl alcohol) – in the anatomical organs of barley seedlings is shown. In sprouts, roots, shells and endosperm higher fatty alcohols are distributed unevenly. The predominant aliphatic alcohol is tetracosanol, found in all the studied anatomical parts of the seedling is dodecanol. Treatment of barley seeds before germination in the electromagnetic field of ultrahigh frequency allowed to increase the content of almost all studied alcohols. Conclusions. After microwave treatment, the number of detectable aliphatic alcohols increased by 1,67 times relative to the control. The higher fatty alcohols are unevenly distributed over the organs of the barley seedling – the maximum is noted in the sprouts, the minimum – in the endosperm. Barley sprouts can be considered as a potential source of lignocerine and begenyl alcohols, where their content ishigh and is 26,20 and 5,67 %, respectively. The content of tetracosanolcan be increased more than twice by pre-microwave treatment of barley grain.
- Published
- 2020
- Full Text
- View/download PDF
9. Analysis of docosanol using GC/MS: Method development, validation, and application to ex vivo human skin permeation studies
- Author
-
Reena Murthy, Praveen Kolimi, Srinivas Ajjarapu, Ikhlas A. Khan, Bharathi Avula, S. Narasimha Murthy, Mei Wang, and Vijay Kumar Shankar
- Subjects
Isopropyl palmitate ,Chromatography ,Pharmaceutical Science ,Pharmacy ,Permeation ,Bioequivalence ,Analytical Chemistry ,Docosanol ,chemistry.chemical_compound ,chemistry ,Drug Discovery ,Electrochemistry ,medicine ,Selected ion monitoring ,Gas chromatography ,Gas chromatography–mass spectrometry ,Spectroscopy ,Ex vivo ,medicine.drug - Abstract
Docosanol is the only US Food and Drug Administration (FDA) approved over-the-counter topical product for treating recurrent oral-facial herpes simplex labialis. Validated analytical methods for docosanol are required to demonstrate the bioequivalence of docosanol topical products. A gas chromatography/selected ion monitoring mode mass spectrometry (GC/SIM-MS) method was developed and validated for docosanol determination in biological samples. Docosanol and isopropyl palmitate (internal standard) were separated on a high-polarity GC capillary column with (88% cyanopropyl)aryl-polysiloxane employed as the stationary phase. The ions of m/z 83 and 256 were selected to monitor docosanol and isopropyl palmitate, respectively; the total run time was 20 min. The GC/SIM-MS method was validated in accordance with USFDA guidelines, and the results met the USFDA acceptance criteria. The docosanol calibration standards were linear in the 100–10000 ng/mL concentration range (R2 > 0.994). The recoveries for docosanol from the receptor fluid and skin homogenates were >93.2% and >95.8%, respectively. The validated method was successfully applied to analyze ex vivo human cadaver skin permeation samples. On applying Abreva® cream tube and Abreva® cream pump, the amount of docosanol that penetrated human cadaver skin at 48 h was 21.5 ± 7.01 and 24.0 ± 6.95 ng/mg, respectively. Accordingly, we concluded that the validated GC/SIM-MS was sensitive, specific, and suitable for quantifying docosanol as a quality control tool. This method can be used for routine analysis as a cost-effective alternative to other techniques.
- Published
- 2022
10. Comparison of Topical Antiviral Agents for Labial Cold Sores (Herpes Labialis)
- Published
- 2007
11. Researchers Submit Patent Application, 'Bisphosphocin Gel Formulations And Uses Thereof', for Approval (USPTO 20200360415)
- Subjects
Bacterial infections ,Physical fitness ,Infection ,Docosanol ,Antibacterial agents -- Intellectual property ,Methicillin -- Intellectual property ,Health - Abstract
2020 DEC 12 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]
- Published
- 2020
12. Patent Issued for Process For The Preparation Of Docosanol (USPTO 10,836,693)
- Subjects
Aurobindo Pharma Ltd. -- Intellectual property ,Physical fitness ,Pharmaceutical industry -- Intellectual property ,Docosanol ,Health - Abstract
2020 DEC 5 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Aurobindo Pharma Ltd. has been issued patent number 10,836,693, according to news [...]
- Published
- 2020
13. 'Use Of Benzofuran Lignans To Induce Il-25 Expression And Suppress Mammary Tumor Metastasis' in Patent Application Approval Process (USPTO 20200289454)
- Subjects
Nafarelin -- Intellectual property ,Verteporfin -- Intellectual property ,Women's health ,Miltefosine ,Ganirelix -- Intellectual property ,Suramin -- Intellectual property ,Decitabine ,Sargramostim ,Perflubron -- Intellectual property ,Cetrorelix -- Intellectual property ,Carboplatin -- Intellectual property ,Ibandronate sodium -- Intellectual property ,Docosanol ,Breast cancer ,Cancer metastasis ,Lanreotide ,Antineoplastic agents -- Intellectual property ,Dolasetron -- Intellectual property ,Health ,Women's issues/gender studies - Abstract
2020 OCT 8 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors Yang, Ning-Sun (New Taipei, TW); Kuo, Yueh-Hsiung (Taipei, [...]
- Published
- 2020
14. Patent Issued for Non-Specific Delayed-Type Hypersensitivity Response To Treat Herpes Simplex Virus Infection (USPTO 10,744,084)
- Subjects
Physical fitness ,Herpes simplex ,Virus diseases ,Skin ,Herpes simplex virus ,Docosanol ,Allergy ,Health - Abstract
2020 SEP 5 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a [...]
- Published
- 2020
15. Patent Issued for Process For The Synthesis Of Docosanol (USPTO 10,723,682)
- Subjects
Physical fitness ,Docosanol ,Health - Abstract
2020 AUG 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Biophore India Pharmaceuticals PVT. Ltd. (Hyderabad, India) has been issued patent number [...]
- Published
- 2020
16. 'Anti-Hcmv Compositions And Methods' in Patent Application Approval Process (USPTO 20200140429)
- Subjects
Anti-HIV agents -- Methods ,Physical fitness -- Methods ,Antiviral agents -- Intellectual property -- Methods ,Letermovir -- Intellectual property -- Methods ,Lopinavir ,Emtricitabine ,Docosanol ,Cidofovir ,Efavirenz ,Enfuvirtide ,Valganciclovir ,Obesity ,Tipranavir ,Adefovir dipivoxil ,Fosamprenavir ,Pleconaril ,Peramivir ,Penciclovir ,Fomivirsen ,Trifluridine ,Editors ,Atazanavir ,Maraviroc ,Health - Abstract
2020 MAY 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A patent application by the inventors Remiszewski, Stacy (Doylestown, PA); Koyuncu, Emre [...]
- Published
- 2020
17. Patent Issued for Compositions Containing Cyclodextrin-Based Metal Organic Frameworks (USPTO 10,583,147)
- Subjects
Permethrin ,Neomycin -- Intellectual property ,Benzocaine -- Intellectual property ,Penciclovir -- Intellectual property ,Meclocycline -- Intellectual property ,Cyclodextrins -- Intellectual property ,Physical fitness ,Dextrins -- Intellectual property ,Docosanol ,Antibacterial agents -- Intellectual property ,Mupirocin -- Intellectual property ,Tetracyclines ,Obesity ,Editors ,Health - Abstract
2020 MAR 28 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A patent by the inventors Limketkai, Benjie N. (Hesperia, CA); Botros, Youssry [...]
- Published
- 2020
18. Intracellular imaging of docosanol in living cells by coherent anti-Stokes Raman scattering microscopy.
- Author
-
Sixian You, Yuan Liu, Arp, Zane, Youbo Zhao, Chaney, Eric J., Marjanovic, Marina, and Boppart, Stephen A.
- Subjects
- *
RAMAN scattering , *CELL lines , *KERATINOCYTES , *CELL membranes , *CYTOPLASM - Abstract
Docosanol is an over-the-counter topical agent that has proved to be one of the most effective therapies for treating herpes simplex labialis. However, the mechanism by which docosanol suppresses lesion formation remains poorly understood. To elucidate its mechanism of action, we investigated the uptake of docosanol in living cells using coherent anti-Stokes Raman scattering microscopy. Based on direct visualization of the deuterated docosanol, we observed highly concentrated docosanol inside living cells 24 h after drug treatment. In addition, different spatial patterns of drug accumulation were observed in different cell lines. In keratinocytes, which are the targeted cells of docosanol, the drug molecules appeared to be docking at the periphery of the cell membrane. In contrast, the drug molecules in fibroblasts appeared to accumulate in densely packed punctate regions throughout the cytoplasm. These results suggest that this molecular imaging approach is suitable for the longitudinal tracking of drug molecules in living cells to identify cell-specific trafficking and may also have implications for elucidating the mechanism by which docosanol suppresses lesion formation. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
19. In Silico Analysis of Antiviral Activity of Analog Curcumin Compounds
- Author
-
Esti Mulatsari, Nidya Luciana Dewi, Titiek Martati, and Esti Mumpuni
- Subjects
Docosanol ,chemistry.chemical_compound ,Chemistry ,In silico ,Protein Data Bank (RCSB PDB) ,medicine ,Curcumin ,Biological activity ,Target protein ,Cyclopentanone ,Combinatorial chemistry ,medicine.drug ,Bioavailability - Abstract
Some studies state that curcumin analog compounds can improve the bioavailability and biological activity of curcumin. One of the methods to predict the bioactivity of curcumin was computational using molecular docking method. This study has done bioactivity tests of curcumin analog compounds as antiviral using the molecular docking method with the software used are PLANTS, YASARA, MarvinSketch, and Pymol for visualization. This study used analog curcumin compounds derived from previous research. This study used five different viral reseptor types. The maraviroc, docosanol, ribavirin, and zanamivir were used as compound control in this research. The validated target protein consists of 5 (five) receptors with PDB codes 1V2I, 4WEG, 2HWI, 2QAD, and 3ALP. Based on this research, compounds that are predicted active as antiviral on each receptors that are: 2,5-bis(3,5-ditertbutyl-4-hydroxy benzyl)cyclopentanone (1V2I), 1,7- diphenyl-1,6-heptadiene-3,5-dione (4WEG), 1,7-bis(3,4-dibenzyloxiphenyl)-1,6-heptadiene-3,5-dione (2HWI), and 2,5-bis(3,5-ditertbutyl-4-hydroxybenzyl)cyclopentanone (3ALP).
- Published
- 2020
20. Advances in the Pharmacotherapy of Periodontal and Oral Mucosal Diseases
- Author
-
R. Slezák, L. Ryšková, V. Paulusová, Z. Šustová, I. Berglová, and V. Buchta
- Subjects
periodontal tissue ,oral mucous membrane ,antimicrobial photodynamic therapy ,toluidine blue o ,methylen blue ,octenidine ,chlorhexidine ,eugenol ,docosanol ,capsaicine ,amifostine ,Dentistry ,RK1-715 - Abstract
Introduction: There are many of drugs useful for topical or systemic treatment of diseases of periodontal tissue and oral mucous membrane. Their correct administration and efficacy depend strictly on adeqnate of information regarding their properties. Aim: The review deals with some drugs newly available in Czech Republic and related therapeutic procedures used in the treatment of periodontal and mucosal diseases. Therapeutic agents: For topical chemical inhibition of the dental plaque are dedicated octenidine, kationic antiseptic pyridine derivate, and combination of classic bis-biguanide derivate chlorhexidine with aromatic agent eugenol. As adjuvant chemotherapeutics in the treatment of periodontitis serve systems for targeted antimicrobial photodynamic therapy based on the use of photosensitizers as producers of the singlet oxygen, namely toluidine blue O and methylen blue. The source of monochromatic light for their pohotoactivation is laser device. Saturated alcohol docosanol with antiviral acitivity serves in topical therapy of labial herpes. Vanillinamide alkaloid capsaicine is selective agonist of vanilloid receptore TRPV 1 of sensitive nerves. Patch product Qutenza has been recently used for higly effective topical treatment of neuropatic pain. It could be potentially very useful agent in the treatment of some forms of atypical facial pain. Irradiation of salivary glands results in association with its dosis in the damage of various grade of the glandular parenchyma associated with postirradiative hyposialia. Cytoprotective prodrug amifostine releases active thiol after its dephosphorylation. It is recommended for the protection of the glandular parenchyma against adverse effects of antitumorous drugs and therapeutic irradiation in the region of the head and neck. Conclusion: Spectrum of therapeutic agents useful in the treatment of periodontal and mucosal diseases raises permanently. Efficacy of their application is connected with sufficient information of professionals and correct and early diagnosis of the disease, as well.
- Published
- 2012
- Full Text
- View/download PDF
21. Patent Application Titled 'Identification Of Additional Anti-Persister Activity Against Borrelia Burgdorferi From An Fda Drug Library' Published Online (USPTO 20190008848)
- Subjects
Physical fitness ,Artemisinin ,Lyme disease ,Verteporfin ,Carbenicillin ,Thonzonium bromide ,Penicillin G ,Efavirenz ,Methylene blue ,Florfenicol ,Antibacterial agents ,Antiviral agents ,Antiprotozoan agents ,Obesity ,Trifluridine ,Metronidazole ,Pyrimethamine ,Penciclovir ,Docosanol ,Tinidazole ,Tazobactam ,Rifamycins ,Anopheles ,Rifaximin ,Health - Abstract
2019 FEB 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]
- Published
- 2019
22. An Alternative Treatment for Vaginal Cuff Wart: a Case Report
- Author
-
Nikolaos Blontzos, Evgenia Karavioti, Anastasia Prodromidou, George Vorgias, Victoria Psomiadou, Christos Iavazzo, Alexandros Fotiou, and Athanasios Douligeris
- Subjects
0301 basic medicine ,beta-Glucans ,Vaginal Diseases ,lcsh:Medicine ,Imiquimod ,0302 clinical medicine ,curcumin ,Cervical cancer ,HPV infection ,virus diseases ,General Medicine ,Middle Aged ,Vaginal cuff ,Drug Combinations ,aloe vera ,Colposcopy ,Condylomata Acuminata ,030220 oncology & carcinogenesis ,vaginal cuff wart ,Vaginal Creams, Foams, and Jellies ,Female ,Squamous Intraepithelial Lesions of the Cervix ,Fatty Alcohols ,medicine.symptom ,Papanicolaou Test ,medicine.drug ,medicine.medical_specialty ,HPV ,Antineoplastic Agents ,Phyllanthus emblica ,Lesion ,Docosanol ,03 medical and health sciences ,Adjuvants, Immunologic ,medicine ,Humans ,Lactic Acid ,Vaginal Smears ,business.industry ,Papillomavirus Infections ,lcsh:R ,Indian Grapefruit (AMLA) ,medicine.disease ,Dermatology ,Alternative treatment ,030104 developmental biology ,Treatment modality ,Plant Preparations ,business ,Phytotherapy - Abstract
Human papillomavirus (HPV) has been directly related to acuminate warts and cervical cancer, the second most common neoplasia among women. Given the lack of treatment against the virus itself, many medications have been utilised, mainly aiming in modifying the host’s immunological response. We present the case of a 54 years old postmenopausal patient with a history of vaginal cuff wart and HPV persistence that we managed in our clinic for 6 months with a mix of curcumin, aloe vera, amla and other natural ingredients. As the patient was found to be intolerant to imiquimod (one of the most common conservative methods of treatment) we attempted the use of curcumin, which was applied to the area of the wart three times per week for 6 months. Both clinical and colposcopical improvement was noted in regular clinic visits with regression of the lesion. The outcome of this case encourages our view that curcumin should be considered as a significant treatment modality against HPV infection and acuminate warts.
- Published
- 2020
23. Current Drugs to Treat Infections with Herpes Simplex Viruses-1 and -2
- Author
-
Lauren A. Sadowski, Zachary W. Greeley, Barry J. Margulies, and Rista Upadhyay
- Subjects
0301 basic medicine ,Foscarnet ,Ganciclovir ,vidarabine ,medicine.medical_specialty ,ganciclovir ,viruses ,Herpesvirus 2, Human ,Biological Availability ,Virus Attachment ,amenamevir ,Signs and symptoms ,DNA-Directed DNA Polymerase ,Herpesvirus 1, Human ,Review ,cidofovir ,Microbiology ,Antiviral Agents ,Docosanol ,nelfinavir ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Virology ,Drug Resistance, Viral ,medicine ,Humans ,030212 general & internal medicine ,Amenamevir ,Intensive care medicine ,Vidarabine ,Nucleic Acid Synthesis Inhibitors ,business.industry ,foscarnet ,Herpes Simplex ,Virus Internalization ,HSV-2 ,HSV-1 ,QR1-502 ,030104 developmental biology ,Infectious Diseases ,Nelfinavir ,chemistry ,acyclovir ,docosanol ,business ,medicine.drug ,Cidofovir - Abstract
Herpes simplex viruses-1 and -2 (HSV-1 and -2) are two of the three human alphaherpesviruses that cause infections worldwide. Since both viruses can be acquired in the absence of visible signs and symptoms, yet still result in lifelong infection, it is imperative that we provide interventions to keep them at bay, especially in immunocompromised patients. While numerous experimental vaccines are under consideration, current intervention consists solely of antiviral chemotherapeutic agents. This review explores all of the clinically approved drugs used to prevent the worst sequelae of recurrent outbreaks by these viruses.
- Published
- 2021
24. THE CHANGES IN THE CONTENT OF ALIPHATIC ALCOHOLS IN BARLEY SEEDLINGS UNDER THE INFLUENCE OF AN ULTRAHIGH FREQUENCY ELECTROMAGNETIC FIELD
- Author
-
E. P. Kondratenko, M. G. Kurbanova, A. S. Sukhikh, and O. M. Soboleva
- Subjects
Electromagnetic field ,cetyl alcohol ,Materials science ,lignocerine alcohol ,dodecanol ,microwave ,Analytical chemistry ,food and beverages ,barley ,sprouts ,laurine alcohol ,Ultrahigh frequency ,begenyl alcohol ,lcsh:Biology (General) ,electromagnetic field ,higher fatty alcohols ,hexadecanol ,Content (measure theory) ,docosanol ,tetracosanol ,lcsh:QH301-705.5 - Abstract
Background. Higher fatty alcohols are a valuable raw material for pharmacology and can serve as an adaptogen in crop production, reducing post-stress effects in the cultivation of crops. Policosanols are linear saturated aliphatic alcohols with carbon atoms ranging from 20–24 to 32–34. Cereal germ contains some of the policosanols and can serve as a potential source for the isolation, purification, and further use of this class of chemical compounds. The purpose of the research is to study the features of the higher fatty alcohols content in various anatomical organs of barley seedlings under the influence of an ultra-high frequency electromagnetic field. Materials and methods. The content of some higher fatty alcohols in barley seedlings after grain processing by ultrahigh frequency electromagnetic fields was determined by the method of chromatography-mass spectrometry. Results. The character of distribution of 4 fatty alcohols – tetraconanol (lignocerin alcohol), docosanol (begenyl alcohol), dodecanol (lauric alcohol) and hexadecanol (cetyl alcohol) – in the anatomical organs of barley seedlings is shown. In sprouts, roots, shells and endosperm higher fatty alcohols are distributed unevenly. The predominant aliphatic alcohol is tetracosanol, found in all the studied anatomical parts of the seedling is dodecanol. Treatment of barley seeds before germination in the electromagnetic field of ultrahigh frequency allowed to increase the content of almost all studied alcohols. Conclusions. After microwave treatment, the number of detectable aliphatic alcohols increased by 1,67 times relative to the control. The higher fatty alcohols are unevenly distributed over the organs of the barley seedling – the maximum is noted in the sprouts, the minimum – in the endosperm. Barley sprouts can be considered as a potential source of lignocerine and begenyl alcohols, where their content ishigh and is 26,20 and 5,67 %, respectively. The content of tetracosanolcan be increased more than twice by pre-microwave treatment of barley grain.
- Published
- 2020
25. Inhibition of biofilm and biofilm-associated virulence factor production in methicillin-resistant Staphylococcus aureus by docosanol
- Author
-
Shunmugiah Karutha Pandian, Venkateswaran Krishnan, Selvaraj Alagu Lakshmi, Wilson Aruni, James Prabhanand Bhaskar, Selvapandi Pandipriya, and Sivasamy Sethupathy
- Subjects
0106 biological sciences ,0301 basic medicine ,Methicillin-Resistant Staphylococcus aureus ,Erythrocytes ,Virulence Factors ,Virulence ,Bioengineering ,Biology ,medicine.disease_cause ,01 natural sciences ,Applied Microbiology and Biotechnology ,Hemolysis ,Virulence factor ,Microbiology ,Docosanol ,03 medical and health sciences ,Antibiotic resistance ,010608 biotechnology ,medicine ,Animals ,Humans ,Sheep ,Biofilm ,Biofilm matrix ,Hemolysin ,General Medicine ,Methicillin-resistant Staphylococcus aureus ,Anti-Bacterial Agents ,030104 developmental biology ,Biofilms ,Fatty Alcohols ,Transcriptome ,Biotechnology ,medicine.drug - Abstract
Antimicrobial resistance is a major public health concern in infection control. Hence, a multi-pronged approach is necessary to curb the severity of infections. The present study entails the identification of docosanol (fatty alcohol) from Streptomyces as a novel antibiofilm agent which can target the virulence factors of MRSA. Results showed that docosanol as a potent antibiofilm agent and found to inhibit several virulence factors of MRSA. The antibiofilm efficacy of docosanol analyzed through light and scanning electron microscopy showed a significant reduction in adherent cells. Moreover, analysis of three-dimensional structure of biofilm matrix by confocal laser scanning microscope demonstrated effective antibiofilm potential of docosanol. In addition, docosanol reduced the survival rate of MRSA in healthy human blood and enhanced the neutrophil-mediated killing by interfering with hemolysin production. RT-qPCR analysis revealed the down regulation of several virulence genes, possibly by affecting the expression of the accessory gene regulator (agr) system and transcriptional regulator sarA. These findings suggest that docosanol could effectively reduce the biofilm phenotype and virulence production, and thus becomes a promising candidate to treat MRSA infections.
- Published
- 2019
26. Nové možnosti ve farmakoterapii chorob parodontu a ústní sliznice.
- Author
-
Slezák, R., Ryšková, L., Paulusová, V., Šustová, Z., Berglová, I., and Buchta, V.
- Subjects
- *
DRUGS , *THERAPEUTICS , *DRUG therapy , *ORAL mucosa diseases - Abstract
Introduction: There are many of drugs useful for topical or systemic treatment of diseases of periodontal tissue and oral mucous membrane. Their correct administration and efficacy depend strictly on adeqnate of information regarding their properties. Aim: The review deals with some drugs newly available in Czech Republic and related therapeutic procedures used in the treatment of periodontal and mucosal diseases. Therapeutic agents: For topical chemical inhibition of the dental plaque are dedicated octenidine, kationic antiseptic pyridine derivate, and combination of classic bis-biguanide derivate chlorhexidine with aromatic agent eugenol. As adjuvant chemotherapeutics in the treatment of periodontitis serve systems for targeted antimicrobial photodynamic therapy based on the use of photosensitizers as producers of the singlet oxygen, namely toluidine blue O and methylen blue. The source of monochromatic light for their pohotoactivation is laser device. Saturated alcohol docosanol with antiviral acitivity serves in topical therapy of labial herpes. Vanillinamide alkaloid capsaicine is selective agonist of vanilloid receptore TRPV 1 of sensitive nerves. Patch product Qutenza has been recently used for higly effective topical treatment of neuropatic pain. It could be potentially very useful agent in the treatment of some forms of atypical facial pain. Irradiation of salivary glands results in association with its dosis in the damage of various grade of the glandular parenchyma associated with postirradiative hyposialia. Cytoprotective prodrug amifostine releases active thiol after its dephosphorylation. It is recommended for the protection of the glandular parenchyma against adverse effects of antitumorous drugs and therapeutic irradiation in the region of the head and neck. Conclusion: Spectrum of therapeutic agents useful in the treatment of periodontal and mucosal diseases raises permanently. Efficacy of their application is connected with sufficient information of professionals and correct and early diagnosis of the disease, as well. [ABSTRACT FROM AUTHOR]
- Published
- 2012
27. Uso de un Líquido Iónico como Catalizador para la Oxidación de Alcoholes Hidrofóbicos de Alto Peso Molecular.
- Author
-
Guajardo, Nadia, Santana, Jorge, and Carlesi, Carlos
- Subjects
- *
OXIDATION , *HYDROPHOBIC surfaces , *MOLECULAR weights , *IONIC liquids , *CATALYSTS , *ALCOHOL , *REACTIVE oxygen species - Abstract
Catalytic batch oxidation runs of an hydrophobic high molecular weight alcohol (docosanol) to the acid were performed using a functionalized ionic liquid composed by an Aliquat®336 cation and a polyperoxometalate {PO4[WO(O2)2]4}3- anion as a catalyst. The active oxygen is efficiently transferred by the catalyst from the aqueous to the alcoholic phase in accordance with an experimentally validated reaction scheme. Only the hydrogen peroxide was used effectively as an oxidant, giving an 81 % conversion and a 55% yield after 6 hours at 90°C, with a H2O2/alcohol molar ratio that equal 3 and an alcohol/catalyst mass ratio that equal 100. The calculated kinetic constants, at 90°C, for the docosanol oxidation to the aldehyde intermediate and the further oxidation towards docosanoic acid were 0,26 and 1,3 L mole-1 h-1, respectively. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
28. Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs
- Author
-
Marcelletti, John F.
- Subjects
- *
HERPESVIRUSES , *VIRAL replication , *DRUG interactions - Abstract
Interactions between docosanol (n-docosanol, behenyl alcohol) and nucleoside or pyrophosphate analogs were investigated in vitro. The anti-HSV activity of acyclovir (ACV) was synergistically enhanced by treatment of cells with docosanol as judged by inhibition of progeny virus production and plaque formation. This drug interaction between ACV and docosanol was observed with laboratory strains of herpes simplex virus types 1 and 2 (HSV-1 and HSV-2), oral and genital clinical isolates of HSV, cytomegalovirus (CMV), and varicella zoster virus (VZV). Near optimal concentrations of docosanol plus ACV inhibited HSV replication >99% more than either drug alone, including emergence of ACV-resistant variants. The response was observed with African Green Monkey kidney cells, normal human foreskin cells, and normal human lung cells. Treatment of cells with docosanol also synergistically intensified the inhibition of HSV production by all tested nucleoside analogs, including trifluorothymidine (TFT), adenine arabinoside (Ara-A), and ribavirin. An additive anti-HSV effect was observed with docosanol and phosphonoformate (PFA). No evidence was found for either synergistic inhibition of cellular DNA synthesis or induction of overt cellular toxicity when docosanol was combined with ACV, TFT, Ara-A, ribavirin, PFA, 8-azaguanine, or 5-fluorouracil. The ability of docosanol treatment to increase the antiviral activities of nucleoside analog antiviral drugs, coupled with a lack of toxic interactions, translates to substantial improvements in drug selectivity ratios. [Copyright &y& Elsevier]
- Published
- 2002
- Full Text
- View/download PDF
29. Correction to: Successful Delivery of Zidovudine-Loaded Docosanol Nanostructured Lipid Carriers (Docosanol NLCs) into Rat Brain
- Author
-
Anupam Sarma, Lopamudra Dutta, Tapash Chakraborty, Sanjoy Das, Malay K. Das, and Biswajit Mukherjee
- Subjects
Docosanol ,Zidovudine ,Chemistry ,medicine ,Pharmacology ,Rat brain ,medicine.drug - Published
- 2019
30. Case 2: Diagnostic Dilemma - Crusty Lips
- Author
-
Easwar Natarajan
- Subjects
medicine.medical_specialty ,business.industry ,Lower lip ,Upper lip ,Diagnostic dilemma ,medicine.disease ,Dermatology ,Docosanol ,Cold sore ,stomatognathic diseases ,Penciclovir ,medicine ,Sun exposure ,business ,medicine.drug - Abstract
This 22-year-old woman is referred to you by her physician for evaluation and management of the findings noted on her lips. The patient reports that around 4 months ago, she developed a “cold sore” on the lower lip likely due to prolonged sun exposure during a sailing trip. Her initial attempts to address this with over-the-counter docosanol cream were unsuccessful. She consulted with her physician who prescribed penciclovir cream. The lesions were unresponsive after two courses of penciclovir and continued to progress in severity and extent (they involved the whole lower lip and upper lip vermilion). She was prescribed valacyclovir PO and has been on this medication for the past 3 months.
- Published
- 2019
31. Successful Delivery of Zidovudine-Loaded Docosanol Nanostructured Lipid Carriers (Docosanol NLCs) into Rat Brain
- Author
-
Biswajit Mukherjee, Sanjoy Das, Anupam Sarma, Lopamudra Dutta, Malay K. Das, and Tapash Chakraborty
- Subjects
Docosanol ,Zidovudine ,Blood serum ,Pharmacokinetics ,Chemistry ,In vivo ,Drug delivery ,Systemic administration ,Cmax ,medicine ,Pharmacology ,medicine.drug - Abstract
The major challenges to the clinical application of zidovudine are its moderate aqueous solubility, relative short half-life, and incapability to go across BBB after systemic administration makes the brain one of the dominant HIV reservoirs. We investigated the development of zidovudine-loaded NLCs based on docosanol and oleic acid which were further surface modified with PEG4000 and HAS. The drug content and entrapment efficiencies were assessed by UV analysis. The mean diameter of the SyLN was found to be at 54.7 ± 1.4 nm with a zeta potential of −21.6 ± 0.2 mV and relatively low polydispersity. The NLCs showed excellent stability in the refrigerated condition, in blood serum and were safe for IV administration. In vitro release studies showed a sustained release profile of zidovudine in aCSF. In vivo plasma and brain pharmacokinetics investigation in a rat model showed that SyLN and SyLN-Peg NLCs rapidly reached the brain and yielded higher MRT, Cmax, and AUC. The rat brain pharmacokinetic data confirm the brain localization and accumulation of the developed NLCs delivering AZT in a sustained manner for a prolonged period of time, which is further confirmed by CLSM images of brain cryosections labeled with SyLN-C6 NLCs. Our results suggest that the developed docosanol NLCs could be a promising drug delivery system for long-term brain delivery of zidovudine in the treatment of Neuro-AIDS.
- Published
- 2019
32. EPA: FORMALDEHYDE AMONG NEXT CHEMICALS TO UNDERGO RISK EVALUATION
- Subjects
Formaldehyde ,Docosanol ,Risk assessment ,Polymer industry ,Chlorinated solvents ,Phthalates ,Flame retardants ,Phthalate plasticizers ,Esters ,Health ,Polymers ,News, opinion and commentary - Abstract
FALLS CHURCH, VA -- The following information was released by the American Industrial Hygiene Association (AIHA): EPA has finalized its list of the next 20 'high-priority' chemicals for upcoming risk [...]
- Published
- 2020
33. GC–MS profiling and in silico prediction of MAPK receptor activation by fatty acids of watercress oil for hair growth marketed in Saudi Arabia
- Author
-
Hassan A. Alhazmi, Mohammed Al Bratty, and Neelaveni Thangavel
- Subjects
chemistry.chemical_classification ,SFDA ,Chemistry ,Hair growth ,Watercress ,In silico ,Fatty acid ,Fatty alcohol ,General Chemistry ,Absorption (skin) ,MAPK ,lcsh:Chemistry ,Docosanol ,chemistry.chemical_compound ,lcsh:QD1-999 ,Phytochemical ,Saturated fatty acid ,medicine ,GC–MS ,Food science ,Gas chromatography–mass spectrometry ,medicine.drug - Abstract
Watercress oil (WCO) is the seed oil of Nasturtium officinale, Brassicaceae family. WCO is a cosmetic for hair growth approved by the Saudi Food and Drug Authority (SFDA). The study aimed to analyze by GC–MS, the phytochemical profile and the safety of WCO as a cosmetic according to SFDA, validates the traditional method of applying hot oil mixtures to the scalp, and also reports the pH, UV absorption, and in-silico binding mechanism of fatty acids for hair growth. The absorption of UV-B light (284.50 nm and 290.60 nm) by WCO suggests that it acts as a sunscreen for the scalp. The pH of the marketed WCO, 5.53 ± 0.02, shall not damage the scalp and hair. The GC–MS analysis confirmed fatty acids as the principal constituents (65.65%) of WCO composed of monounsaturated fatty acids (MUFAs): cis-11-Octadecenoic acid (17.14%), cis-9-Octadecenoic acid (17.11%), cis-13-Eicosenoic acid (11.13%), cis-11-Eicosenoic acid (3.48%), and cis-13-Docosenoic acid (1.64%); saturated fatty acid: n-Hexadecanoic acid (12.89%); saturated fatty alcohol: Docosanol (2.26%). The GC–MS results also confirmed the absence of colorants, toxic solvents, and therapeutic substances in WCO, a cosmetic requirement, according to SFDA. The densities of mixtures of WCO + Coconut oil was 0.801 ± 0.03 mg/mL, and WCO + Olive oil was 0.885 ± 0.01 mg/mL; the kinematic viscosities of WCO + Coconut oil was 21.5 ± 0.0 mm2/s, and WCO + Olive oil was 28.6 ± 0.1 mm2/s at 40℃, which was lesser than the mixtures at 27℃. The decrease in density and viscosity of hot oil mixtures can improve the penetration of oil into the hair filament, which substantiated the traditional application method. In-silico, molecular docking results revealed that all the fatty acid constituents except Docosanol contributed to the hair growth promotion effect by activating MAPK1, MAPK3, and MAPKp38 receptors. This work is the first report on WCO to establish the phytochemical profile to confirm SFDA standard by GC–MS and its in-silico efficiency of activation of MAPK receptors for hair growth.
- Published
- 2021
34. Current Drugs to Treat Infections with Herpes Simplex Viruses-1 and -2.
- Author
-
Sadowski, Lauren A., Upadhyay, Rista, Greeley, Zachary W., and Margulies, Barry J.
- Subjects
- *
HERPES simplex , *DRUG utilization , *ANTIVIRAL agents , *DRUGS , *INFECTION - Abstract
Herpes simplex viruses-1 and -2 (HSV-1 and -2) are two of the three human alphaherpesviruses that cause infections worldwide. Since both viruses can be acquired in the absence of visible signs and symptoms, yet still result in lifelong infection, it is imperative that we provide interventions to keep them at bay, especially in immunocompromised patients. While numerous experimental vaccines are under consideration, current intervention consists solely of antiviral chemotherapeutic agents. This review explores all of the clinically approved drugs used to prevent the worst sequelae of recurrent outbreaks by these viruses. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
35. Painful Oral Lesions
- Author
-
Istvan A. Hargitai
- Subjects
medicine.medical_specialty ,Triamcinolone acetonide ,genetic structures ,Pemphigoid, Benign Mucous Membrane ,Recurrent aphthous stomatitis ,Docosanol ,03 medical and health sciences ,0302 clinical medicine ,Facial Pain ,medicine ,Humans ,Erythema multiforme ,skin and connective tissue diseases ,General Dentistry ,Erythema Multiforme ,integumentary system ,business.industry ,Lichen Planus ,food and beverages ,030206 dentistry ,medicine.disease ,Dermatology ,Fluocinonide ,stomatognathic diseases ,030220 oncology & carcinogenesis ,Penciclovir ,aphthous ulcer ,Prednisolone ,Stomatitis, Aphthous ,business ,Pemphigus ,medicine.drug - Abstract
Painful oral vesiculoerosive diseases (OVD) include lichen planus, pemphigus vulgaris, mucous membrane pemphigoid, erythema multiforme, and recurrent aphthous stomatitis. OVD lesions have an immunopathic cause. Treatment is aimed at reducing the immunologic and the following inflammatory response. The mainstay of OVD management is topical or systemic corticosteroids to include topical triamcinolone, fluocinonide, and clobetasol, whereas systemic medications used in practice can include dexamethasone, prednisone, and prednisolone. Oral herpetic lesions can be primary or recurrent. If management is desired, they can be treated by topical or systemic antiviral drugs. Topical antiviral creams include prescription acyclovir, penciclovir and over-the-counter docosanol.
- Published
- 2018
36. Antiproliferative evaluation of tall-oil docosanol and tetracosanol over CHO-K1 and human melanoma cells
- Author
-
Araceli Olivares, Claudia Altamirano, and Mauricio Vergara
- Subjects
Future studies ,Tall oil ,lcsh:Biotechnology ,Melanoma ,Cell ,Biology ,medicine.disease ,Human melanoma cells ,Applied Microbiology and Biotechnology ,%22">Pinus ,Docosanol ,medicine.anatomical_structure ,lcsh:Biology (General) ,Polycosanols ,Cell culture ,lcsh:TP248.13-248.65 ,Immunology ,Growth-arrested ,medicine ,Cancer research ,CHO-K1 cells ,Human melanoma ,lcsh:QH301-705.5 ,Biotechnology ,medicine.drug - Abstract
Article history:Received 21 January 2015Accepted 2 May 2015Available online 28 May 2015Keywords:CHO-K1 cellsGrowth-arrestedHuman melanoma cellsPolycosanols Background:Polycosanolsderivedfromplantspecieshavetraditionallybeenusedinmedicineasantiproliferativeagentsfortreatingvariousviruses(primarilytheherpessimplexvirus).However,fewstudieshavestudiedtheireffects on hyperproliferative cell lines. In this work, the antiproliferative capacity of polycosanols from tall-oilpitch, obtained from black liquor soaps in the kraft pulping process of cellulose (specifically from Pinus radiata,Pinus taede,andEucalyptus globulus), was evaluated on CHO-K1 and CRL-1974 human melanoma cell lines.Results: The proliferative capacities and cell viabilities were measured for 72 and 140 h, respectively. TreatmentwithdocosanolproduceddifferentialeffectsontheCHO-K1andhumanmelanomacellsandsignificantlyaffectedtheir proliferation rates, but not their cell viabilities. Tetracosanol produced a significant negative effect on theproliferation of human melanoma cells, and this effect was less than that caused by docosanol. However, it hadno effect on the proliferation of CHO-K1 cells and did not induce any significant effect on the viability of thestudied cell lines.Conclusion: Docosanol and tetracosanol induced antiproliferative effects on the studied cell lines and exhibitedsignificantly greater effects on the oncogenic cell lines. Prior to this study, the capacity of these polycosanolshas never been investigated. Future studies will be necessary to determine their mechanisms of action onthese cell systems.©2015Pontificia UniversidadCatolicadeValparaiso. Production and hosting byElsevierB.V. Allrights reserved.
- Published
- 2015
37. Policosanol variation in olive oil as a result of variety, ripening, and storage
- Author
-
Vlasta Piližota, Marina Lukić, Barbara Sladonja, and Igor Lukić
- Subjects
Olive oil ,Policosanol ,Ripening degree ,Storage ,Variety ,Chemistry ,Ripening ,General Chemistry ,Mass spectrometric ,Industrial and Manufacturing Engineering ,Docosanol ,Botany ,medicine ,Food science ,Oil storage ,Food Science ,Biotechnology ,medicine.drug - Abstract
Despite their importance as bioactive compounds and authentication parameters in olive oil, the response of policosanol aliphatic alcohols to even the most influential sources of variability is practically unknown. To investigate policosanol variation in olive oil as a result of variety, ripening, and oil storage temperature, 36 samples were subjected to gas chromatographic (GC-FID) and mass spectrometric (GC-MS) analysis, and results were processed by univariate (ANOVA) and multivariate (SLDA) statistics. The concentration (mg/100 g) and relative amount (%) of pentacosanol accounted for the most variation due to variety. The largest influence of ripening was observed for pentacosanol (%) and docosanol (%). Docosanol, tricosanol, and tetracosanol amounts mostly increased during ripening, whereas those of pentacosanol, hexacosanol, heptacosanol, and octacosanol decreased in Črna and Rosinjola oils, whereas Buža showed different patterns in some cases. Variations as a result of storage were lower and inconsistent. Results suggest that the investigated olive oils retained the bulk of their health beneficial features of policosanol origin throughout shelf-life. Relatively successful differentiation of oils achieved by multivariate models pointed to the potential use of policosanol alcohols as chemical indicators of varietal origin which are independent on ripening degree, and vice versa, applicable both for fresh and stored oils.
- Published
- 2015
38. Policosanol in Tomato (Solanum lycopersicum L.) Seed Oil: the Effect of Cultivar
- Author
-
Marco Capocasale and Angelo Maria Giuffrè
- Subjects
biology ,Chemistry ,General Chemical Engineering ,Alcohol ,General Medicine ,General Chemistry ,biology.organism_classification ,Docosanol ,Horticulture ,chemistry.chemical_compound ,Agronomy ,Unsaponifiable ,medicine ,Composition (visual arts) ,Cultivar ,Solanum ,Policosanol ,Chemical composition ,medicine.drug - Abstract
Soxhlet-petroleum ether extraction was used to obtain oil from tomato seeds. Three tomato cultivars from South Italy (Principe Borghese, Rebelion F1 and San Marzano) were studied. Policosanol is a mixture of long chain linear fatty alcohols (n-alkanols), its content and composition was found to be highly significantly influenced by cultivar. Seven fatty alcohols were detected: docosanol (C22-ol), tricosanol (C23-ol), tetracosanol (C24-ol), pentacosanol (C25-ol), hexacosanol (C26-ol), heptacosanol (C27-ol) and octacosanol (C28-ol). The highest policosanol content was found in Principe Borghese 71.88 mg/Kg. Octacosanol was the linear alcohol present in highest quantity, i.e. 38-42% of the total linear alcohols detected in tomato seed oils (TSO). Chemometrics was applied to study the differences among cultivars. The sum of even long chained fatty alcohols was always more than 95% of the total policosanol content. One-way ANOVA and principal component analysis well differentiated the three cultivars.
- Published
- 2015
39. EPA MATERIALS DISCUSS 'HIGH-PRIORITY' CHEMICALS, INCLUDING FORMALDEHYDE
- Subjects
Formaldehyde ,Docosanol ,Risk assessment ,Polymer industry ,Safety regulations ,Chlorinated solvents ,Phthalates ,Flame retardants ,Phthalate plasticizers ,Esters ,Polymers ,News, opinion and commentary - Abstract
FALLS CHURCH, VA -- The following information was released by the American Industrial Hygiene Association (AIHA): Last week, EPA proposed to designate 20 chemicals as 'high-priority' substances for upcoming risk [...]
- Published
- 2019
40. EPA PUBLISHES SUPPORTING MATERIALS FOR CHEMICALS DESIGNATED AS 'LOW PRIORITY'
- Subjects
Docosanol ,Safety regulations ,News, opinion and commentary - Abstract
FALLS CHURCH, VA -- The following information was released by the American Industrial Hygiene Association (AIHA): Last week, EPA proposed to designate 20 chemicals as 'low-priority substances' under the Toxic [...]
- Published
- 2019
41. Global Herpes Labialis Treatment market 2019: size, share, demand, trends, growth and 2025 forecasts explored in latest research
- Subjects
Penciclovir ,Cold sores ,Docosanol ,Databases ,Online databases ,Herpesvirus infections ,Company growth ,Business ,Business, international - Abstract
M2 PRESSWIRE-July 11, 2019-: Global Herpes Labialis Treatment market 2019: size, share, demand, trends, growth and 2025 forecasts explored in latest research (C)1994-2019 M2 COMMUNICATIONS RDATE:11072019 Wiseguyreports.Com Adds 'Herpes Labialis [...]
- Published
- 2019
42. Patent Issued for Use Of Plant Extracts Against Herpes Simplex Virus (USPTO 10,716,821)
- Subjects
Docosanol ,Biological products -- Intellectual property ,Business ,Health - Abstract
2020 AUG 7 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- Universite Du Quebec Chicoutimi (Chicoutimi, Canada) has been issued patent number 10,716,821, according [...]
- Published
- 2020
43. Patent Issued for Antiviral Compositions (USPTO 10,561,609)
- Subjects
Anti-HIV agents ,Antiviral agents -- Intellectual property ,Reverse transcriptase inhibitors ,Dolutegravir ,Protease inhibitors -- Intellectual property ,Povidone -- Intellectual property ,Delavirdine ,Lopinavir ,Emtricitabine ,Docosanol ,Darunavir ,Elvitegravir ,Efavirenz ,Rilpivirine ,Boceprevir ,Tipranavir ,Adefovir dipivoxil ,Fosamprenavir ,Peramivir ,Penciclovir ,Trifluridine ,Editors ,Atazanavir ,Etravirine ,Health - Abstract
2020 MAR 2 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- A patent by the inventors Foster, Alison J. (Liverpool, GB); Long, James (Liverpool, GB); Rannard, [...]
- Published
- 2020
44. Patent Issued for Anti-HCMV Compositions And Methods (USPTO 10,556,894)
- Subjects
Anti-HIV agents -- Methods ,Antiviral agents -- Methods -- Intellectual property ,Letermovir -- Methods -- Intellectual property ,Lopinavir ,Emtricitabine ,Docosanol ,Cidofovir ,Efavirenz ,Enfuvirtide ,Valganciclovir ,Birth defects ,Tipranavir ,Adefovir dipivoxil ,Fosamprenavir ,Pleconaril ,Peramivir ,Penciclovir ,Fomivirsen ,Trifluridine ,Editors ,Atazanavir ,Maraviroc ,Health - Abstract
2020 FEB 25 (NewsRx) -- By a News Reporter-Staff News Editor at Virus Weekly -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the [...]
- Published
- 2020
45. Patent Application Titled 'Peptides And Uses For Managing Viral Infections' Published Online (USPTO 20190367567)
- Subjects
Anti-HIV agents ,Influenza vaccines -- Intellectual property ,Antiviral agents -- Intellectual property ,Dolutegravir ,Protease inhibitors -- Intellectual property ,Peptides ,Influenza ,Amino acids -- Intellectual property ,Vaccination ,Lopinavir ,Emtricitabine ,Docosanol ,Efavirenz ,Enfuvirtide ,Tipranavir ,Adefovir dipivoxil ,Peramivir ,Trifluridine ,Editors ,Atazanavir ,Maraviroc ,Delavirdine ,Recurrence (Disease) ,Containers ,Darunavir ,Cidofovir ,Raltegravir ,Valganciclovir ,Boceprevir ,Fosamprenavir ,Pleconaril ,Penciclovir ,Fomivirsen ,Business ,Health - Abstract
2019 DEC 27 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent [...]
- Published
- 2019
46. Metabolic engineering of Saccharomyces cerevisiae for production of very long chain fatty acid-derived chemicals
- Author
-
Quanli Liu, Leonie Wenning, Tao Yu, Yongjin J. Zhou, Florian David, Anastasia Krivoruchko, Jens Nielsen, and Verena Siewers
- Subjects
0106 biological sciences ,0301 basic medicine ,reductases ,Science ,Saccharomyces cerevisiae ,Very long chain fatty acid ,jojoba oil ,General Physics and Astronomy ,elongation ,yeast ,01 natural sciences ,Microbiology ,General Biochemistry, Genetics and Molecular Biology ,Article ,Industrial Biotechnology ,Docosanol ,Metabolic engineering ,Applied microbiology ,03 medical and health sciences ,chemistry.chemical_compound ,genetic modifications ,010608 biotechnology ,medicine ,2. Zero hunger ,chemistry.chemical_classification ,acetyl-coenzyme ,Multidisciplinary ,biology ,pathway ,Biochemistry and Molecular Biology ,Fatty acid ,General Chemistry ,biology.organism_classification ,Yeast ,arabidopsis ,030104 developmental biology ,synthase ,Biochemistry ,chemistry ,Fatty acid elongation ,Science & Technology - Other Topics ,Fermentation ,biosynthesis ,medicine.drug - Abstract
Production of chemicals and biofuels through microbial fermentation is an economical and sustainable alternative for traditional chemical synthesis. Here we present the construction of a Saccharomyces cerevisiae platform strain for high-level production of very-long-chain fatty acid (VLCFA)-derived chemicals. Through rewiring the native fatty acid elongation system and implementing a heterologous Mycobacteria FAS I system, we establish an increased biosynthesis of VLCFAs in S. cerevisiae. VLCFAs can be selectively modified towards the fatty alcohol docosanol (C22H46O) by expressing a specific fatty acid reductase. Expression of this enzyme is shown to impair cell growth due to consumption of VLCFA-CoAs. We therefore implement a dynamic control strategy for separating cell growth from docosanol production. We successfully establish high-level and selective docosanol production of 83.5 mg l−1 in yeast. This approach will provide a universal strategy towards the production of similar high value chemicals in a more scalable, stable and sustainable manner., Production of chemicals by microbial fermentation is an economical alternative to chemical synthesis. Here the authors re-engineer the yeast S. cerevisiae to produce the very long chain fatty alcohol docosanol by expressing a heterologous Mycobacteria fatty acid synthase and a specific fatty acid reductase.
- Published
- 2017
47. Long-chain fatty alcohols from evening primrose oil inhibit the inflammatory response in murine peritoneal macrophages
- Author
-
A. Fernández Arche, Maria Ángel-Martín, M.C. Pérez-Camino, M.D. García-Giménez, and S. Montserrat-de la Paz
- Subjects
Lipopolysaccharide ,Cell Survival ,Interleukin-1beta ,Onagraceae ,Pharmacology ,theater ,Dinoprostone ,Nitric oxide ,Oenothera biennis ,Docosanol ,Mice ,chemistry.chemical_compound ,Drug Discovery ,Animals ,Plant Oils ,Medicine ,Evening Primrose Oil ,gamma-Linolenic Acid ,Phospholipases A2, Secretory ,Policosanol ,Nitrites ,Inflammation ,biology ,Tumor Necrosis Factor-alpha ,business.industry ,biology.organism_classification ,Evening primrose ,Thromboxane B2 ,Gene Expression Regulation ,Linoleic Acids ,chemistry ,Biochemistry ,Macrophages, Peritoneal ,Fatty Alcohols ,business ,theater.play ,medicine.drug - Abstract
Evening primrose (Oenothera biennis L., Onagraceae) is a wild medicinal plant of Central American origin that is now one of the most widely used herbal medicines in different parts of the world. Oil extracted from it seeds is traditionally used in the treatment of eczema, asthma, rheumatoid arthritis, breast problem, premenstrual and menopausal syndrome, all they have an inflammatory component. The present study demonstrates the in vitro anti-inflammatory effect of long-chain fatty alcohols, minor compounds isolated from Evening primrose oil (EPO).A mixture of long chain fatty alcohols (LCFAs) was isolated from the non-triacylglycerol fraction of the EPO. Hexacosanol (C26OH: 38.65%), tetracosanol (C24OH: 31.59%), docosanol (C22OH: 11.36%) and octocosanol (C28OH: 7.64%), were the major constituents, identified and quantified by GC and GC-MS. LCFA was tested with LPS stimulated murine peritoneal macrophage. This fraction, significantly and dose-dependently decreased nitric oxide production induced by LPS (P0.001) and the inhibitory effect seems to be consequence of an action at the level of the inducible nitric-oxide synthethase (iNOS) gene enzyme expression rather than to a direct inhibitory action on enzyme activity. The release of PLA2 and TXB2 also was significantly inhibited by LCFAs (P0.001) although LCFAs did not affect to PGE2 generation, however the western blot assay showed that LCFAs reduced cyclooxygenase-2 enzyme gene expression at all doses assayed. In the same way, the secretion of inflammatory cytokines interleukin 1β (IL-1β) and tumour necrosis factor α (TNF-α) from LPS-stimulated murine macrophage, were also significantly reduced (P0.001).These results demonstrates the anti-inflammatory activity of LCFAs, providing an additional value about the role of bioactive minor compounds in the beneficial effect of EPO and supports its traditional uses in inflammatory processes management.
- Published
- 2014
48. Muscle extract of Arothron immaculatus regulates the blood glucose level and the antioxidant system in high-fat diet and streptozotocin induced diabetic rats
- Author
-
T. Sivasudha, Ganesan Arun, Rajendran Rajaram, Balázs Gulyás, Govindaraju Archunan, Nambirajan Gayathri, Parasuraman Padmanabhan, and K. Kaleshkumar
- Subjects
Blood Glucose ,Male ,Antioxidant ,medicine.medical_treatment ,Arothron ,Pharmacology ,Diet, High-Fat ,01 natural sciences ,Biochemistry ,Antioxidants ,Diabetes Mellitus, Experimental ,Docosanol ,Diabetes mellitus ,Drug Discovery ,medicine ,Animals ,Hypoglycemic Agents ,Insulin ,Rats, Wistar ,Muscle, Skeletal ,Molecular Biology ,Metoprolol ,biology ,Tetraodontiformes ,010405 organic chemistry ,Chemistry ,Organic Chemistry ,Streptozotocin ,biology.organism_classification ,medicine.disease ,In vitro ,Rats ,0104 chemical sciences ,010404 medicinal & biomolecular chemistry ,Docosahexaenoic acid ,medicine.drug - Abstract
In the present study pufferfish, Arothron immaculatus muscle methanol extract (AIME) was used to evaluate the antidiabetic activity against the high-fat diet (HFD) in streptozotocin (STZ) induced diabetic rat models. Initially, the In vitro antioxidant activity of the different muscle extract was evaluated which showed that AIME has higher efficiency to scavenge the free radicals. The animal study results revealed that the AIME could decrease the blood glucose level after 14 days of oral treatment and recover the animal from the severe progression of the disease. The LC-ESI/MS analysis of AIME extract revealed the presence of compounds such as docosahexaenoic acid, adrenic acid, docosanol, codeine and metoprolol. Among these compounds, docosahexaenoic acid, adrenic acid and docosanol are reported for its antidiabetic studies. Hence, the muscle is recommended to consume by humans as natural food in order to overcome the development of diabetes. This is the first study on the muscle extract of marine pufferfish which is used as antidiabetic agent to treat the diabetes-induced in the animal model.
- Published
- 2019
49. Topical application of docosanol- or stearic acid-containing creams reduces severity of phenol burn wounds in mice.
- Author
-
Khalil, M. H., Marcelletti, John F., Katz, Lee R., Katz, David H., and Pope, Laura E.
- Subjects
- *
SKIN injuries , *ANTISEPTICS , *STEARIC acid , *BURNS & scalds , *THERAPEUTICS - Abstract
Because of their reported antiviral and anti-inflammatory activities, cream formulations containing n-docosanol (docosanol) or stearic acid were tested for effects on chemically-induced burns in mice. In this model, injury was induced by painting the abdomens of mice with a chloroform solution of phenol. This was followed by the topical application of test substances 0.5, 3, and 6 h later. Progression of the wounds was assessed by a single evaluator after 8 h, using a numerical score of gross morphology. Docosanol- and stearic acid-containing creams substantially and reproducibly lessened the severity and progression of skin lesions compared to untreated sites with a 76% and 57% reduction in mean lesion scores, respectively. Untreated wounds appeared red and ulcerated; docosanol cream-treated wounds showed only slight erythema. [ABSTRACT FROM AUTHOR]
- Published
- 2000
- Full Text
- View/download PDF
50. Researchers Submit Patent Application, 'A Process For The Preparation Of Docosanol', for Approval (USPTO 20190330131)
- Subjects
Aurobindo Pharma Ltd. -- Intellectual property ,Otic preparations ,Pharmaceutical industry -- Intellectual property ,Docosanol ,Editors ,Business ,Pharmaceuticals and cosmetics industries ,Health - Abstract
2019 NOV 18 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Sukumar, [...]
- Published
- 2019
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.